Also trades as: ZYDUSWELL.BO (BSE) · $vol 0M
ZYDUSWELL.NS NSE
Zydus Wellness Limited
1W: -5.2%
1M: -6.7%
3M: -17.4%
YTD: +18.4%
1Y: +26.6%
3Y: +73.3%
5Y: +15.8%
₹484.75 ($5.03)
-8.50 (-1.72%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.4B
-62.9% ▼
5Y CAGR: -13.2%
Capital Expenditures
$1.0B
-53.4% ▼
5Y CAGR: +38.9%
Free Cash Flow
$393M
-87.5% ▼
5Y CAGR: -31.8%
Dividends Paid
$382M
-20.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$440M
+430.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3.1B | $2.9B | $2.7B | $3.6B | $2.0B |
| Depreciation & Amort. | $236M | $250M | $238M | $284M | $1.5B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$1.1B | -$2.4B | -$438M | -$268M | -$2.1B |
| Other Non-Cash Items | $135M | $158M | -$5M | $196M | $82M |
| Operating Cash Flow | $2.4B | $917M | $2.5B | $3.8B | $1.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$754M | -$450M | -$285M | -$663M | -$1.0B |
| Acquisitions (Net) | $0 | $413M | -$7M | -$3.7B | -$28.5B |
| Investment Purchases | -$259M | -$414M | -$51M | $0 | $0 |
| Investment Sales | $54M | $1M | $4M | $2.1B | $420M |
| Other Investing | $100M | -$400M | -$1.4B | $44M | -$24M |
| Investing Cash Flow | -$860M | -$849M | -$1.8B | -$2.2B | -$29.1B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.7B | -$890M | $315M | -$1.4B | $28.3B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$319M | -$319M | -$319M | -$318M | -$382M |
| Other Financing | -$337M | -$176M | -$253M | -$155M | -$60M |
| Financing Cash Flow | -$2.3B | -$1.4B | -$257M | -$1.9B | $27.9B |
| Net Change in Cash | -$829M | -$1.3B | $430M | -$133M | $440M |
| Cash End of Period | $1.7B | $381M | $800M | $667M | $1.1B |
| Free Cash Flow | $1.6B | $467M | $2.2B | $3.1B | $393M |